|
Stay up-to-date with the latest O&T News in Europe
Read EFORT's official Newsletter with a round up of all EFORT activities
|
|
|
|
|
|
|
Save the date for the upcoming EFORT Webinar
|
On Monday 25 September 2023 at 19:00 CET, the EFORT Webinar will focus on Cement Revisited. This event to be chaired by Rami Madanat, Finland & Bernd Grimm, Luxembourg will focus on the use of bone cement in orthopaedics.
The objectives of this webinar are:
- To understand the history and composition of bone cement;
- To gain an understanding of the current trends and outcomes of cement use in hip and knee arthroplasty;
- To identify the role of antibiotics and other additives in bone cement.
An application has been made to the UEMS EACCME® for CME accreditation of this webinar. See the webinar page for updated information.
This Webinar is organised by EFORT independent of any commercial educational support.
|
|
|
|
|
|
|
|
EFORT Robotic Travelling Fellowship supported by Stryker
|
From their visits at our host sites in London and Glasgow,
three of our travelling fellows from the UK share their insights with you
|
In January 2023, Dr. Talal Al-Jabri and Dr. Baseem Choudhry travelled together for 3 weeks and visited Prof. Fares Haddad and his team at the University College London Hospital, Princess Grace Hospital in London as well as Mr. Nick Ohly and his team at the Golden Jubilee Hospital in Glasgow to gain novel insights within the field of robotics applied to hip and knee arthroplasty.
Dr. Al-Jabri reports that "The EFORT Robotic Fellowship represented an extraordinary amalgamation of surgical skill development, academic enrichment, and professional networking…" and “…epitomizes the collaborative and dynamic essence of our specialty, and it is with immense gratitude and honour that I reflect on having undertaken this pivotal experience.”
|
Then, in April 2023, Dr. Haroon Rehman also visited both host centres even though for a slightly shorter duration. He says that through this fellowship
"I have gained a deeper understanding of their potential to optimise patient outcomes in joint replacement surgeries and a comprehensive understanding of the clinical applications and benefits of robotic surgery."
Explore their Robotic Travelling Fellowship journeys through their own words!
|
|
|
|
|
|
|
High-quality instructional peer-reviewed articles
across the whole field of Orthopaedics and Traumatology
|
|
|
|
|
|
|
Meet EOR at the British Orthopaedic Association Annual Congress
|
|
|
The publishing team for EFORT Open Reviews will be attending the BOA Annual Congress 2023 from 19 to 22 September 2023 in Liverpool, ACC (UK).
Please drop by the journal stand (booth 3) to talk to us about publishing with the journal’ or about becoming a reviewer!
|
|
|
|
|
|
|
|
|
|
Save the dates for these upcoming CORE-MD Webinars
|
The CORE-MD consortium organises webinars to present the outcome of the work performed by partners.
Each event will run from 17:00 to 18:15 CET. Registrations will open soon.
In the meantime, you can save these dates to your calendars.
|
The clinical evaluation of artificial intelligence and standalone software: keeping the balance between benefit and risk
Monday 17 October 2023 📅 Add this event to my calendar
|
What is the evidence for high-risk medical devices in the field of cardiovascular disease and diabetes?
Results and implications of the CORE-MD systematic reviews
Monday 06 November 2023 📅 Add this event to my calendar
|
International standards for clinical investigations of high-risk medical devices – the CORE-MD analysis with recommendations to regulators
Monday 20 November 2023 📅 Add this event to my calendar
|
IT tools for regulatory science: aggregating available data for assisting Expert Panels and improving post-market surveillance
Monday 05 December 2023 📅 Add this event to my calendar
|
Early clinical investigations of new high-risk medical devices
– a review of European experience
Monday 08 January 2024 📅 Add this event to my calendar
|
|
|
|
|
|
|
CORE-MD is a European Union Horizon 2020 project. It reviews methods for evaluating high-risk medical devices in order to translate expert evidence into advice for EU regulators and to recommend an appropriate balance between innovation, safety , and clinical effectiveness.
|
|
|
|
|
|
|
A quick access to prime educational material
|
|
|
|
|
|
